ArticleEuropean journal of medical research2025
Association of C-reactive protein-triglyceride glucose index with anxiety in American adults: outcomes from NHANES 2007 to 2010.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Impact of chronic comorbidities on psychological and social status in COVID-19 patients.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe novel serum C-reactive protein-triglyceride glucose index (CTI) represents a novel integrative biomarker for inflammation and insulin resistance. Despite this, its association with anxiety status remains underexplored.
aimThis study aims to investigate the relationship between the C-reactive protein-triglyceride glucose index (CTI) and anxiety status.
methodsData were obtained from the National Health and Nutrition Examination Survey database 2007-2010. Associations between CTI (continuous and quartiles) and anxiety outcomes were evaluated using weighted multivariable logistic regression for anxiety status (odds ratios, ORs) and linear regression for anxiety days (β coefficients). RCS regression analysis was employed to model the relationship between CTI and anxiety. Subgroup analysis has been performed to examine potential effect modifications.
resultsBaseline attributes of the nationally representative cohort (weighted N = 172,699,334; unweighted n = 3876) are detailed. Anxiety prevalence reached 25.6% after weighting. Within fully adjusted Model 3, per-unit CTI elevation maintained a positive anxiety association (OR = 1.24, 95% CI 1.08-1.42, p = 0.006). Only participants in the highest CTI quartile (Q4) showed significantly elevated anxiety risk (OR: 1.31, 95% CI 1.02-1.70, P = 0.038) and anxiety days (β: 1.23, 95% CI 0.21-2.25, P = 0.02) compared to Q1, with significant positive trends (P = 0.028 and 0.019, respectively). Smoothed curve fitting coupled with threshold effect analysis revealed a nonlinear CTI-anxiety relationship. Subgroup and sensitivity assessments confirmed stable CTI-anxiety connections throughout population strata.
conclusionThis study highlights a significant association between C-reactive protein-triglyceride glucose index and anxiety status in the NHANES population. Future research should validate its clinical utility for risk stratification and public health interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.